Acta pharmacologica Sinica
Formyl peptide receptor 2 is a potential biomarker and therapeutic target for inflammatory bowel disease.
Wen-Sheng Yang, Xiao-Zhen Wang, Wei Wu, Yuan Li, Guang-Fei Wang, Qing-Tong Zhou, Ming-Wei Wang, Zhi-Ping Li
Published: 202510.1038/s41401-025-01695-4
Abstract
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is characterized by limited treatment options and a therapeutic ceiling. Failure to resolve inflammation is the key driver of disease progression. Formyl pe…
Preview only. Read the full abstract at the source